AKT1 and cancer: As AKT activation is a conserved feedback signaling event induced by TEAD–YAP blockade, we sought to determine whether combination of MGH-CP1 with an AKT inhibitor would have synergistic effects in blocking YAP-dependent cancer cell growth.